The Resistance of Cervical Cancer to Chemotherapy and its Reversal
$441.01
- Hardcover
286 pages
- Release Date
1 December 2025
Summary
Overcoming Chemoresistance in Cervical Cancer: A Comprehensive Guide
The Resistance of Cervical Cancer to Chemotherapy and its Reversal provides a holistic understanding of cervical cancer development, immune-evading mechanisms of HPV, immunotherapies available, methods to study cervical cancer and the development of newer drugs. Content shows the involvement of signaling pathways during chemoresistance in cervical cancer, the involvement of genes in drug resistance, and introduces …
Book Details
| ISBN-13: | 9780443223525 |
|---|---|
| ISBN-10: | 0443223521 |
| Series: | Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy |
| Author: | S. Muthusami |
| Publisher: | Elsevier Science Publishing Co Inc |
| Imprint: | Academic Press Inc |
| Format: | Hardcover |
| Number of Pages: | 286 |
| Release Date: | 1 December 2025 |
| Weight: | 450g |
| Dimensions: | 235mm x 191mm |
About The Author
S. Muthusami
Dr. Sridhar Muthusami completed his Ph.D in endocrinology in 2011 from the University of Madras, India. His doctoral study delineated the molecular mechanism underlying the anabolic actions of Cissus quadrangularis, an indigenous herb believed to exert anabolic effects on bone cells through IGFR. After his Ph.D, he pursued postdoctoral work in the department of Radiation Oncology, Chungbuk National University, South Korea, from 2011 to 2014. There, he worked on the role of Epidermal growth factor/receptor (EGF/EGFR) signaling and its regulation of oncoprotein Fused Toes Homolog (FTS) in cervical cancer cells. He also investigated the role of T0070907/EGCG/cordycepin on cervical cancer cells. Since 2015, he has been with the department of biochemistry, Karpagam Academy of Higher Education (Deemed to be University), serving as Associate Professor and Head at Cancer Research Centre, working on the development of EGFR TKIs for the treatment/management of cervical cancer/pancreatic cancer.
Returns
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.